Literature DB >> 22798666

Chronic exposure to staphylococcal superantigen elicits a systemic inflammatory disease mimicking lupus.

Vaidehi R Chowdhary1, Ashenafi Y Tilahun, Chad R Clark, Joseph P Grande, Govindarajan Rajagopalan.   

Abstract

Chronic nasal and skin colonization with superantigen (SAg)-producing Staphylococcus aureus is well documented in humans. Given that trans-mucosal and trans-cutaneous absorption of SAgs can occur, we determined whether chronic exposure to small amounts of SAg per se could activate autoreactive CD4(+) and CD8(+) T cells and precipitate any autoimmune disease without further external autoantigenic stimulation. Because HLA class II molecules present SAg more efficiently than do mouse MHC class II molecules, HLA-DQ8 transgenic mice were implanted s.c. with mini-osmotic pumps capable of continuously delivering the SAg, staphylococcal enterotoxin B (total of 10 μg/mouse), or PBS over 4 wk. Chronic exposure to staphylococcal enterotoxin B resulted in a multisystem autoimmune inflammatory disease with features similar to systemic lupus erythematosus. The disease was characterized by mononuclear cell infiltration of lungs, liver, and kidneys, accompanied by the production of anti-nuclear Abs and deposition of immune complexes in the renal glomeruli. The inflammatory infiltrates in various organs predominantly consisted of CD4(+) T cells bearing TCR Vβ8. The extent of immunopathology was markedly reduced in mice lacking CD4(+) T cells and CD28, indicating that the disease is CD4(+) T cell mediated and CD28 dependent. The absence of disease in STAT4-deficient, as well as IFN-γ-deficient, HLA-DQ8 mice suggested the pathogenic role of Th1-type cytokines, IL-12 and IFN-γ. In conclusion, our study suggests that chronic exposure to extremely small amounts of bacterial SAg could be an etiological factor for systemic lupus erythematosus.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22798666      PMCID: PMC3462343          DOI: 10.4049/jimmunol.1201097

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  61 in total

1.  Staphylococcus aureus colonization and IgE antibody formation to enterotoxins is increased in nasal polyposis.

Authors:  Thibaut Van Zele; Philippe Gevaert; Jean-Baptiste Watelet; Geert Claeys; Gabriele Holtappels; Cindy Claeys; Paul van Cauwenberge; Claus Bachert
Journal:  J Allergy Clin Immunol       Date:  2004-10       Impact factor: 10.793

2.  Expression of staphylococcal superantigens during nasal colonization is not sufficient to induce a systemic neutralizing antibody response in humans.

Authors:  M Burian; D Grumann; S Holtfreter; C Wolz; C Goerke; B M Bröker
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-05-31       Impact factor: 3.267

3.  Expression and function of HLA-DR3 and DQ8 in transgenic mice lacking functional H2-M.

Authors:  G Rajagopalan; M K Smart; S Cheng; C J Krco; K L Johnson; C S David
Journal:  Tissue Antigens       Date:  2003-08

4.  Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis.

Authors:  C A Stegeman; J W Tervaert; W J Sluiter; W L Manson; P E de Jong; C G Kallenberg
Journal:  Ann Intern Med       Date:  1994-01-01       Impact factor: 25.391

5.  Evidence for the effects of a superantigen in rheumatoid arthritis.

Authors:  X Paliard; S G West; J A Lafferty; J R Clements; J W Kappler; P Marrack; B L Kotzin
Journal:  Science       Date:  1991-07-19       Impact factor: 47.728

6.  Humanlike immune response of human leukocyte antigen-DR3 transgenic mice to staphylococcal enterotoxins: a novel model for superantigen vaccines.

Authors:  Luis DaSilva; Brent C Welcher; Robert G Ulrich; M Javad Aman; Chella S David; Sina Bavari
Journal:  J Infect Dis       Date:  2002-05-23       Impact factor: 5.226

7.  Epicutaneous sensitization with superantigen induces allergic skin inflammation.

Authors:  Dhafer Laouini; Seiji Kawamoto; Ali Yalcindag; Paul Bryce; Emiko Mizoguchi; Hans Oettgen; Raif S Geha
Journal:  J Allergy Clin Immunol       Date:  2003-11       Impact factor: 10.793

8.  Occurrence of antibodies to teichoic acid in patients with diseases other than staphylococcal infection.

Authors:  U Larinkari; M Leirisalo; P J Pentikäinen; U Turunen; P Pikkarainen; M Vuoristo; J Lumio; T Räsänen; V V Valtonen
Journal:  J Med Microbiol       Date:  1983-02       Impact factor: 2.472

9.  Respiratory epithelial cells regulate lung inflammation in response to inhaled endotoxin.

Authors:  Shawn J Skerrett; H Denny Liggitt; Adeline M Hajjar; Robert K Ernst; Samuel I Miller; Christopher B Wilson
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2004-03-26       Impact factor: 5.464

10.  Defective CD8 T cell memory following acute infection without CD4 T cell help.

Authors:  Joseph C Sun; Michael J Bevan
Journal:  Science       Date:  2003-04-11       Impact factor: 47.728

View more
  23 in total

1.  Superantigens produced by catheter-associated Staphylococcus aureus elicit systemic inflammatory disease in the absence of bacteremia.

Authors:  Jin-Won Chung; Kerryl E Greenwood-Quaintance; Melissa J Karau; Ashenafi Tilahun; Shahryar Rostamkolaei Khaleghi; Vaidehi R Chowdhary; Chella S David; Robin Patel; Govindarajan Rajagopalan
Journal:  J Leukoc Biol       Date:  2015-05-15       Impact factor: 4.962

2.  Concomitant Disruption of CD4 and CD8 Genes Facilitates the Development of Double Negative αβ TCR+ Peripheral T Cells That Respond Robustly to Staphylococcal Superantigen.

Authors:  Vaidehi R Chowdhary; Ashton Krogman; Ashenafi Y Tilahun; Mariam P Alexander; Chella S David; Govindarajan Rajagopalan
Journal:  J Immunol       Date:  2017-05-03       Impact factor: 5.422

3.  Altered Mitochondrial Homeostasis during Systemic Lupus Erythematosus Impairs Neutrophil Extracellular Trap Formation Rendering Neutrophils Ineffective at Combating Staphylococcus aureus.

Authors:  Andrew J Monteith; Jeanette M Miller; Jonathan M Williams; Kelsey Voss; Jeffrey C Rathmell; Leslie J Crofford; Eric P Skaar
Journal:  J Immunol       Date:  2021-12-20       Impact factor: 5.422

4.  Systemic inflammatory response elicited by superantigen destabilizes T regulatory cells, rendering them ineffective during toxic shock syndrome.

Authors:  Ashenafi Y Tilahun; Vaidehi R Chowdhary; Chella S David; Govindarajan Rajagopalan
Journal:  J Immunol       Date:  2014-08-04       Impact factor: 5.422

5.  Staphylococcal Enterotoxin B-specific monoclonal antibody 20B1 successfully treats diverse Staphylococcus aureus infections.

Authors:  Avanish K Varshney; Xiaobo Wang; Matthew D Scharff; Jennifer MacIntyre; Richard S Zollner; Oleg V Kovalenko; Luis R Martinez; Fergus R Byrne; Bettina C Fries
Journal:  J Infect Dis       Date:  2013-08-06       Impact factor: 5.226

6.  Mini-Osmotic Pump Infusion Model to Investigate the Systemic Effects of Chronic Continuous Exposure to Staphylococcal Superantigen in Mice.

Authors:  Ashton L Krogman; Vaidehi Chowdhary; Govindarajan Rajagopalan
Journal:  Methods Mol Biol       Date:  2016

7.  Staphylococcus aureus Colonization Is Increased on Lupus Skin Lesions and Is Promoted by IFN-Mediated Barrier Disruption.

Authors:  Sirisha Sirobhushanam; Navya Parsa; Tamra J Reed; Celine C Berthier; Mrinal K Sarkar; Grace A Hile; Lam C Tsoi; Josh Banfield; Craig Dobry; Alexander R Horswill; Johann E Gudjonsson; J Michelle Kahlenberg
Journal:  J Invest Dermatol       Date:  2019-12-23       Impact factor: 8.551

8.  Prevalence of sea, seb, sec, sed, and tsst-1 genes of Staphylococcus aureus in nasal carriage and their association with multiple sclerosis.

Authors:  Zahra Pakbaz; Mohammad Ali Sahraian; Samira Sabzi; Mahmood Mahmoodi; Mohammad Reza Pourmand
Journal:  Germs       Date:  2017-12-05

Review 9.  The staphylococcal enterotoxin (SE) family: SEB and siblings.

Authors:  Teresa Krakauer; Bradley G Stiles
Journal:  Virulence       Date:  2013-04-19       Impact factor: 5.882

Review 10.  Update on staphylococcal superantigen-induced signaling pathways and therapeutic interventions.

Authors:  Teresa Krakauer
Journal:  Toxins (Basel)       Date:  2013-09-24       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.